文献速递肺结节与肺癌

肿瘤大小与组织学类型对临床淋巴结阴性NSCLC肺段切除与肺叶切除术后结局的影响

The Effect of Tumor Size and Histologic Findings on Outcomes After Segmentectomy vs Lobectomy for Clinically Node-Negative Non-Small Cell Lung Cancer.
PubMed 文献 · Chest · 2020-07-08

基于2004-2015年美国国家癌症数据库(NCDB),纳入143,040例cT1-3N0M0非小细胞肺癌患者,比较肺叶切除(95%)与肺段切除(5%)的总生存。多因素Cox回归发现肿瘤大小、组织学类型与手术方式存在显著三重交互作用(P < .001)。腺癌肿瘤大小约10 mm以上、鳞癌约15 mm以上时,肺叶切除生存优于肺段切除;神经内分泌肿瘤未见交互作用。

要点

  • 腺癌肿瘤>约10 mm时肺叶切除生存优于肺段切除。
  • 鳞癌肿瘤>约15 mm时肺叶切除生存优于肺段切除。
  • 神经内分泌肿瘤中肿瘤大小与手术方式无交互作用。

核心结论

  • 基于组织学类型的不同肿瘤大小阈值可识别从肺叶切除相比肺段切除获益最大和最小的淋巴结阴性NSCLC人群。

研究设计与样本

  • 回顾性队列研究,查询2004-2015年NCDB中接受肺段切除或肺叶切除、未行新辅助治疗且无生存数据缺失的cT1-3N0M0 NSCLC患者,共143,040例。

主要发现

  • 135,446例(95%)接受肺叶切除,7,594例(5%)接受肺段切除。
  • 多因素Cox回归显示肿瘤大小、组织学结果与手术方式之间存在显著三重交互作用(P < .001)。
  • 按组织学分层,腺癌肿瘤大小超过约10 mm、鳞状细胞癌超过约15 mm时,肺叶切除与显著改善的生存相关,亚组分析结果一致。
  • 神经内分泌肿瘤患者中未发现肿瘤大小与手术方式之间的交互作用。

临床怎么用

  • 临床淋巴结阴性NSCLC选择肺段切除或肺叶切除时,应结合组织学类型和肿瘤大小评估生存获益。

局限性

  • 研究为基于NCDB的回顾性分析,仅纳入接受肺段切除或肺叶切除、未行新辅助治疗且无生存数据缺失的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The interaction between tumor size and the comparative prognosis of lobar and sublobar resection has been defined poorly. RESEARCH QUESTION: The purpose of this study was to characterize the relationship between tumor size and the receipt of segmentectomy or lobectomy in association with overall survival in patients with clinically node-negative non-small cell lung cancer (NSCLC). STUDY DESIGN AND METHODS: The 2004-2015 National Cancer Database (NCDB) was queried for patients with cT1-3N0M0 NSCLC who underwent segmentectomy or lobectomy without neoadjuvant therapy or missing survival data. The primary outcome was overall survival, which was evaluated using multivariate Cox proportional hazards including an interaction term between tumor size and type of surgery. RESULTS: A total of 143,040 patients were included: 135,446 (95%) underwent lobectomy and 7594 (5%) underwent segmentectomy. In multivariate Cox regression, a significant three-way interaction was found among tumor size, histologic results, and type of surgery (P < .001). When patients were stratified by histologic results, lobectomy was associated with significantly improved survival compared with segmentectomy beyond a tumor size of approximately 10 mm for adenocarcinoma and 15 mm for squamous cell carcinoma that was recapitulated in subgroup analyses. No interaction between tumor size and type of surgery was found for patients with neuroendocrine tumors. INTERPRETATION: In this NCDB study of patients with node-negative NSCLC, we found different tumor size thresholds, based on histologic results, that identified populations of patients who least and most benefitted from lobectomy compared with segmentectomy.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Raman V, Jawitz OK, Voigt SL, et al. The Effect of Tumor Size and Histologic Findings on Outcomes After Segmentectomy vs Lobectomy for Clinically Node-Negative Non-Small Cell Lung Cancer. Chest. 2020. PMID: 32652096. doi:10.1016/j.chest.2020.06.066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。